These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7586289)

  • 61. [Diagnosis of cancers by FDG-PET].
    Ichiya Y
    Fukuoka Igaku Zasshi; 1997 Jan; 88(1):7-10. PubMed ID: 9091463
    [No Abstract]   [Full Text] [Related]  

  • 62. Preclinical stages in subjects at risk for neurological disorders: can PET-FDG tell us more?
    Azari NP; Pietrini P
    J Neurol; 1995 Jan; 242(2):112-4. PubMed ID: 7707087
    [No Abstract]   [Full Text] [Related]  

  • 63. The use of low-dose intravenous insulin in clinical myocardial F-18 FDG PET scanning.
    Lewis P; Nunan T; Dynes A; Maisey M
    Clin Nucl Med; 1996 Jan; 21(1):15-8. PubMed ID: 8741883
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Positron emission tomography in the clinical evaluation of metastatic cancer.
    Fischman AJ
    J Clin Oncol; 1996 Mar; 14(3):691-6. PubMed ID: 8622012
    [No Abstract]   [Full Text] [Related]  

  • 65. [Assessment of myocardial vitality with FDG-PET: still research or ready for general practice?].
    Schröter G; Schwaiger M
    Herz; 1995 Oct; 20(5):350-3. PubMed ID: 7498882
    [No Abstract]   [Full Text] [Related]  

  • 66. Experimental studies on myocardial glucose metabolism of rats with 18F-2-fluoro-2-deoxy-D-glucose.
    Yamada K; Endo S; Fukuda H; Abe Y; Yoshioka S; Itoh M; Kubota K; Hatazawa J; Satoh T; Matsuzawa T
    Eur J Nucl Med; 1985; 10(7-8):341-5. PubMed ID: 3891350
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of compartmental and spectral analysis models of [18F]FDG kinetics for heart and brain studies with PET.
    Bertoldo A; Vicini P; Sambuceti G; Lammertsma AA; Parodi O; Cobelli C
    IEEE Trans Biomed Eng; 1998 Dec; 45(12):1429-48. PubMed ID: 9835192
    [TBL] [Abstract][Full Text] [Related]  

  • 68. On FDG PET metabolic imaging to assess myocardial viability.
    Brunken RC; Go RT; MacIntyre WJ
    J Nucl Med; 2000 Apr; 41(4):25N. PubMed ID: 10768553
    [No Abstract]   [Full Text] [Related]  

  • 69. SUV: standard uptake or silly useless value?
    Keyes JW
    J Nucl Med; 1995 Oct; 36(10):1836-9. PubMed ID: 7562051
    [No Abstract]   [Full Text] [Related]  

  • 70. Iodine-123-labeled glucose analogs: prospects for a single-photon-emitting analog of fluorine-18-labeled deoxyglucose.
    Gatley SJ
    Nucl Med Biol; 1995 Oct; 22(7):829-35. PubMed ID: 8547880
    [No Abstract]   [Full Text] [Related]  

  • 71. F-18 fluorodeoxyglucose and cardiac metabolism.
    Bianco JA
    J Am Coll Cardiol; 1992 Nov; 20(6):1442-3. PubMed ID: 1430697
    [No Abstract]   [Full Text] [Related]  

  • 72. F-18 FDG accumulation in inflamed joints.
    Yasuda S; Shohtsu A; Ide M; Takagi S; Mitomi T; Suzuki Y
    Clin Nucl Med; 1996 Sep; 21(9):740. PubMed ID: 8879882
    [No Abstract]   [Full Text] [Related]  

  • 73. Assessment of cerebrovascular disease with positron emission tomography: attempt of an in vivo model for treatment evaluation of brain glucose metabolism.
    Cinotti L; Croisile B; Laurent B; Le Bars D; Malbezin M; Mauguière F
    Eur Neurol; 1995; 35 Suppl 1():17-22. PubMed ID: 8529724
    [No Abstract]   [Full Text] [Related]  

  • 74. Diffuse F-18 FDG uptake in chronic thyroiditis.
    Yasuda S; Shohsu A; Ide M; Takagi S; Suzuki Y; Tajima T
    Clin Nucl Med; 1997 May; 22(5):341. PubMed ID: 9152546
    [No Abstract]   [Full Text] [Related]  

  • 75. PET with fluorine-18 deoxyglucose for pancreatic disease.
    Klever P; Bares R; Fass J; Büll U; Schumpelick V
    Lancet; 1992 Nov; 340(8828):1158-9. PubMed ID: 1359226
    [No Abstract]   [Full Text] [Related]  

  • 76. Positron emission tomography and autoradiographic studies of glucose utilization following electroconvulsive seizures in humans and rats.
    Ackermann RF; Engel J; Baxter L
    Ann N Y Acad Sci; 1986; 462():263-9. PubMed ID: 3486621
    [No Abstract]   [Full Text] [Related]  

  • 77. Melorheostosis bone scintigraphy and F-18 fluorodeoxyglucose positron emission tomography.
    Kloos RT; Shreve P; Fig L
    Clin Nucl Med; 1996 Oct; 21(10):805-6. PubMed ID: 8896934
    [No Abstract]   [Full Text] [Related]  

  • 78. 'False-positive' uptake of FDG in a hepatic adenoma.
    Patel PM; Alibazoglu H; Ali A; Fordham E; LaMonica G
    Clin Nucl Med; 1997 Jul; 22(7):490-1. PubMed ID: 9227877
    [No Abstract]   [Full Text] [Related]  

  • 79. Normal glucose uptake by tongue and pharyngeal muscles in FDG-PET imaging.
    Segall GM
    J Nucl Med; 1996 Nov; 37(11):1918. PubMed ID: 8917211
    [No Abstract]   [Full Text] [Related]  

  • 80. LBBB: challenging our concept of metabolic heart imaging with fluorine-18-FDG and PET?
    Altehoefer C
    J Nucl Med; 1998 Feb; 39(2):263-5. PubMed ID: 9476933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.